Conversely, low expression of RUNX2, RUNX3, GFI1B, EGR2, HOXD12 and HIF1A was significantly correlated with a poor RFS of HCC patients (Figure S1A). This evidence concerns the gene EGR2 and hepatocellular carcinoma.